Standard-dose protocols are usually the better fit when the patients primary goal is significant weight reduction and they are comfortable with a more traditional titration plan
bioequivalence is concluded if certain criteria are met, including, but not limited to, the ratio of these pharmacokinetic (PK) parameters between the test and reference formulations falling between prespecified criteria with a certain assurance, which vary by each respective guideline [28,29,30]
PlexusDx uses genetic and biomarker insights to contextualize these decisions within a personalized framework
Common reasons for switching include tolerability issues, medication supply shortages, inadequate weight loss response, or NHS commissioning changes
It's the same medical leadership and the same standard of care, with a team built specifically around the weight-loss journey